Literature DB >> 25297893

Long-term psychosocial and behavioral adjustment in individuals receiving genetic test results in Lynch syndrome.

M J Esplen1, J Wong, M Aronson, K Butler, H Rothenmund, K Semotiuk, L Madlensky, C Way, E Dicks, J Green, S Gallinger.   

Abstract

A cross-sectional study of 155 participants who underwent genetic testing for Lynch syndrome (LS) examined long-term psychosocial and behavioral outcomes. Participants completed standardized measures of perceived risk, psychosocial functioning, knowledge, and a questionnaire of screening activities. Participants were on average 47.3 years and had undergone testing a mean of 5.5 years prior. Eighty four (54%) tested positive for a LS mutation and 71 (46%) negative. For unaffected carriers, perceived lifetime risk of colorectal cancer was 68%, and surprisingly, 40% among those testing negative. Most individuals demonstrated normative levels of psychosocial functioning. However, 25% of those testing negative had moderate depressive symptoms, as measured by the Center for Epidemiologic Studies for Depression Scale, and 31% elevated state anxiety on the State-Trait Anxiety Inventory. Being female and a stronger escape - avoidant coping style were predictive of depressive symptoms. For state anxiety, similar patterns were observed. Quality of life and social support were significantly associated with lower anxiety. Carriers maintained higher knowledge compared to those testing negative, and were more engaged in screening. In summary, most individuals adapt to genetic test results over the long term and continue to engage in screening. A subgroup, including some non-carriers, may require added psychosocial support.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Lynch syndrome; colorectal cancer; empirical study; genetic testing; long-term follow-up; psychological adjustment; screening and knowledge

Mesh:

Year:  2014        PMID: 25297893      PMCID: PMC4391982          DOI: 10.1111/cge.12509

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  37 in total

1.  Predictive genetic testing for hereditary non-polyposis colorectal cancer: uptake and long-term satisfaction.

Authors:  K Aktan-Collan; J P Mecklin; H Järvinen; M Nyström-Lahti; P Peltomäki; I Söderling; A Uutela; A de la Chapelle; H Kääriäinen
Journal:  Int J Cancer       Date:  2000-01-20       Impact factor: 7.396

Review 2.  Genetic testing and counseling for hereditary forms of colorectal cancer.

Authors:  G M Petersen; J D Brensinger; K A Johnson; F M Giardiello
Journal:  Cancer       Date:  1999-12-01       Impact factor: 6.860

3.  Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study.

Authors:  I van Oostrom; H Meijers-Heijboer; H J Duivenvoorden; A H J T Bröcker-Vriends; C J van Asperen; R H Sijmons; C Seynaeve; A R van Gool; J G M Klijn; A Tibben
Journal:  Clin Genet       Date:  2007-01       Impact factor: 4.438

4.  Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.

Authors:  Iris van Oostrom; Hanne Meijers-Heijboer; Hugo J Duivenvoorden; Annette H J T Bröcker-Vriends; Christi J van Asperen; Rolf H Sijmons; Caroline Seynaeve; Arthur R Van Gool; Jan G M Klijn; Aad Tibben
Journal:  Patient Educ Couns       Date:  2006-07-26

5.  Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer.

Authors:  Ellen R Gritz; Susan K Peterson; Sally W Vernon; Salma K Marani; Walter F Baile; Beatty G Watts; Christopher I Amos; Marsha L Frazier; Patrick M Lynch
Journal:  J Clin Oncol       Date:  2005-03-20       Impact factor: 44.544

6.  Changes in screening behaviors and attitudes toward screening from pre-test genetic counseling to post-disclosure in Lynch syndrome families.

Authors:  A M Burton-Chase; S R Hovick; S K Peterson; S K Marani; S W Vernon; C I Amos; M L Frazier; P M Lynch; E R Gritz
Journal:  Clin Genet       Date:  2013-03       Impact factor: 4.438

Review 7.  Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium.

Authors:  W Burke; G Petersen; P Lynch; J Botkin; M Daly; J Garber; M J Kahn; A McTiernan; K Offit; E Thomson; C Varricchio
Journal:  JAMA       Date:  1997-03-19       Impact factor: 56.272

Review 8.  Psychological consequences of predictive genetic testing: a systematic review.

Authors:  M Broadstock; S Michie; T Marteau
Journal:  Eur J Hum Genet       Date:  2000-10       Impact factor: 4.246

9.  Understanding why negative genetic test results sometimes fail to reassure.

Authors:  Susan Michie; Jonathan A Smith; Victoria Senior; Theresa M Marteau
Journal:  Am J Med Genet A       Date:  2003-06-15       Impact factor: 2.802

10.  The phases of disclosing BRCA1/2 genetic information to offspring.

Authors:  Susan Clarke; Kate Butler; Mary Jane Esplen
Journal:  Psychooncology       Date:  2008-08       Impact factor: 3.894

View more
  8 in total

Review 1.  Psychosocial Impact of Lynch Syndrome on Affected Individuals and Families.

Authors:  Polymnia Galiatsatos; Heidi Rothenmund; Sylvie Aubin; William D Foulkes
Journal:  Dig Dis Sci       Date:  2015-03-19       Impact factor: 3.199

2.  Psychological Impact of TP53-Variant-Carrier Newborns and Counselling on Mothers: A Pediatric Surveillance Cohort.

Authors:  Amanda Scartezini Gozdziejewski; Clarice Wichinescki Zotti; Isabela Aparecida Moreira de Carvalho; Thairine Camargo Dos Santos; Luana Rayana de Santi Walter; Karin Rosa Persegona Ogradowski; Karin Luiza Dammski; Heloisa Komechen; Monalisa Castilho Mendes; Emanuelle Nunes de Souza; Mariana Martins Paraizo; Ivy Zortea da Silva Parise; Guilherme Augusto Parise; André Luiz Grion; Gislaine Custódio; Rosiane Guetter Mello; Bonald C Figueiredo
Journal:  Cancers (Basel)       Date:  2022-06-15       Impact factor: 6.575

3.  Experience Gained from the Development and Execution of a Multidisciplinary Multi-syndrome Hereditary Colon Cancer Family Conference.

Authors:  Ilana Solomon; Christina Rybak; Lily Van Tongeren; Lili Kuzmich; Kathleen Blazer; Bita Nehoray; Mariana Niell-Swiller; Shawnie Bray; Travis H Bray; Karen Hurley; Jeffrey N Weitzel; Thomas P Slavin
Journal:  J Cancer Educ       Date:  2019-12       Impact factor: 2.037

4.  How does genetic risk information for Lynch syndrome translate to risk management behaviours?

Authors:  Emma Steel; Andrew Robbins; Mark Jenkins; Louisa Flander; Clara Gaff; Louise Keogh
Journal:  Hered Cancer Clin Pract       Date:  2017-01-05       Impact factor: 2.857

5.  "Who Doesn't Like Receiving Good News?" Perspectives of Individuals Who Received Genomic Screening Results by Mail.

Authors:  Annika T Beck; Erica J Sutton; Carolyn P Y Chow; Susan H Curtis; Iftikhar J Kullo; Richard R Sharp
Journal:  J Pers Med       Date:  2021-04-21

Review 6.  Family Adjustment to Hereditary Cancer Syndromes: A Systematic Review.

Authors:  Pedro Gomes; Giada Pietrabissa; Eunice R Silva; João Silva; Paula Mena Matos; Maria Emília Costa; Vanessa Bertuzzi; Eliana Silva; Maria Carolina Neves; Célia M D Sales
Journal:  Int J Environ Res Public Health       Date:  2022-01-30       Impact factor: 3.390

7.  Health-related quality of life in colorectal cancer survivors: are there differences between sporadic and hereditary patients?

Authors:  Allison M Burton-Chase; Wendy M Parker; Kirsten M Donato; Shannon McCormick; Ellen R Gritz; Christopher I Amos; Karen H Lu; Patrick M Lynch; Miguel A Rodriguez-Bigas; Y Nancy You; Susan K Peterson
Journal:  J Patient Rep Outcomes       Date:  2018-05-01

8.  Uptake and predictors of colonoscopy use in family members not participating in cascade genetic testing for Lynch syndrome.

Authors:  Donald W Hadley; Dina Eliezer; Yonit Addissie; Andrea Goergen; Sato Ashida; Laura Koehly
Journal:  Sci Rep       Date:  2020-09-29       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.